Eli Lilly (LLY) Current Assets (2016 - 2025)
Historic Current Assets for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $62.1 billion.
- Eli Lilly's Current Assets rose 9758.43% to $62.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $62.1 billion, marking a year-over-year increase of 9758.43%. This contributed to the annual value of $32.7 billion for FY2024, which is 2725.81% up from last year.
- Eli Lilly's Current Assets amounted to $62.1 billion in Q3 2025, which was up 9758.43% from $49.9 billion recorded in Q2 2025.
- Eli Lilly's 5-year Current Assets high stood at $62.1 billion for Q3 2025, and its period low was $16.6 billion during Q1 2021.
- For the 5-year period, Eli Lilly's Current Assets averaged around $26.5 billion, with its median value being $21.3 billion (2023).
- In the last 5 years, Eli Lilly's Current Assets crashed by 226.47% in 2022 and then skyrocketed by 9758.43% in 2025.
- Quarter analysis of 5 years shows Eli Lilly's Current Assets stood at $18.5 billion in 2021, then fell by 2.26% to $18.0 billion in 2022, then surged by 42.65% to $25.7 billion in 2023, then rose by 27.26% to $32.7 billion in 2024, then skyrocketed by 89.59% to $62.1 billion in 2025.
- Its Current Assets stands at $62.1 billion for Q3 2025, versus $49.9 billion for Q2 2025 and $41.3 billion for Q1 2025.